Estrogen receptor and progesterone receptor status in breast cancer in relation to age, histological grade, size of lesion and lymph node involvement

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 5047-5052

  Sofi, Gulam Nabi ^a   Sofi, Junaid Nabi ^b   Nadeem, Raja ^c   Shiekh, Rayees Yousuf ^d   Khan, Faroze Ahmad ^d   Sofi, Abid Ahmad ^d   Bhat, Hillal Ahmad ^d   Bhat, Rayees Ahmad ^d  

^a Pathologyskims   (India)

^b Khalida Zia Medical College   (India)

^c GOVERNMENT MEDICAL COLLEGE   (India)

^d SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Breast cancer; Estrogen receptor; Preanalytic variables; Progestrone receptor

Indexed keywords

EID: 84874007051     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.10.5047     Document Type: Article

References (57)

1. Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM (2003). Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol, 21, 1973-9.
2. Barnes Dm, Hanby Am (2001). Oestrogen And Progesterone Receptors In Breast Cancer: Past, Present And Future.Histopathology, 38, 271-4.
3. Blesch KS, Davis F, Kamath SK (1999). A comparison of breast and colon cancer incidence rates among native Asian Indians, US immigrant Asian Indians, and whites. J Am Diet Assoc, 99, 1275-7.
4. Bolufer P, Molina R, Ruiz A, et al (1994). Estradiol receptors in combination with neu or myc oncogene amplifications might define new subtypes of breast cancer. Clin Chim Acta, 229, 107-22.
5. Couris CM, Polazzi S, Olive F, et al (2009). Breast cancer incidence using administrative data: correction with sensitivity and specificity. J Clin Epidemiol, 62, 660-6.
6. Deapen D, Liu L, Perkins C, Bernstein L, Ross RK (2002). Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer, 99, 747-50.
7. Desai SB, Moonim MT, Gill AK, et al (2000). Hormone receptor status of breast cancer in India: a study of 798 tumors. Breast, 9, 267-70.
8. Deshpande AD, Jeffe DB, Gnerlich J, et al (2009). Racial Disparities in Breast Cancer Survival: An Analysis by Age and Stage. J Surg Res, 153, 105-13.
9. Dunnwald LK, Rossing MA, Li CI (2007). Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res, 9, R6.
10. Early Breast Cancer Trialists' Collaborative Group (1998). Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet, 35, 1451-67.
11. Fact Sheet No. 297: Cancer. World Hlth Organization. February 2006. Retrieved 2009-03-26.
12. Fatima, TWO AUTHOR, et al (2005). Breast cancer: steroid receptors and other prognostic indicators. J Coll Physicians Surg Pak. 15, 230-3.
13. Fisher ER, Anderson S, Dean S, et al (2005). Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma. Cancer, 103, 164-73.
14. Gajalakshmi P, Natarajan TG, Selvi Rani D, Thangaraj K (2007). A novel BRCA1 mutation in an Indian family with hereditary breast/ovarian cancer. Breast Cancer Res Treat, 101, 3-6.
15. Ghumare SS, Cunningham JE (2007). Breast cancer trends in Indian residents and emigrants portend an emerging epidemic for India. Asian Pac J Cancer Prev, 8, 507-12.
16. Goggins WB, Wong G (2009). Cancer among Asian Indians/Pakistanis living in the United States: low incidence and generally above average survival. Cancer Causes Control, 20, 635-43.
17. Goldhirsch A, Glick JH, Gelber RD, et al (2005). Meeting highlights: international expert consensus on the primary therapy of early breast cancer. Ann Oncol, 16, 1569-83.
18. Gown MA (2008). Current issues in ER and HER2 testing by IHC in breast cancer, Modern Pathol, 21, 8-15.
19. Hammond ME, Hayes DF, Dowsett M, et al (2010). American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer arch pathol lab med. Arch Pathol Lab Med, 134, 907-22.
20. Harvey JM, Clark GM, Osborne CK, et al (1999). Estrogen receptor status by immunohistochemistry is superior to the ligandbinding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol, 17, 1474-81
21. Hawkins RA, Roberts MM, Forrest APM (1980) Estrogen receptors and breast cancer. Current status. Br J Surg, 67, 162-5.
22. Hebert JR, Ghumare SS, Gupta PC (2006). Stage at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States. Asian Pac J Cancer Prev, 7, 547-55.
23. Irvin WJ Jr, Carey LA (2008). What is triple-negative breast cancer. Eur J Cancer, 44, 2799-805.
24. Jack RH, Davies EA, Moller H (2009). Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England. Br J Cancer, 100, 545-50.
25. Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.
26. Kakarala M, Rozek L, Cote M, Liyanage S, Brenner DE (2010). Breast cancer histology and receptor status characterization in Asian Indian and Pakistani women in the U.S. - a SEER analysis. BMC Cancer, 10, 191.
27. Kamath SK, Murillo G, Chatterton RT Jr, et al (1999). Breast cancer risk factors in two distinct ethnic groups: Indian and Pakistani vs. American premenopausal women. Nutr Cancer, 35, 16-26.
28. Kuraparthy S, Reddy KM, Yadagiri LA, et al (2007). Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in Southern India. World J Surg Oncol, 5, 56.
29. La Vecchia C, Franceschi S, Lucchini F, Levi F (1994). International variations and trends in the incidence of breast Cancer in Older Women. Cancer Control, 1, 327-33.
30. Marugame T, Katanoda K (2006). International comparisons of cumulative risk of breast and prostate cancer, from cancer incidence in five continents Vol. VIII. Jpn J Clin Oncol, 36, 399-400.
31. Mohsin SK, Weiss H, Havighurst T, et al (2004). Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol, 17, 1545-54.
32. Morabia A, Costanza MC (2000). Reproductive factors and incidence of breast cancer: an international ecological study. Soz Praventivmed, 45, 247-57.
33. Mori I, Yang Q, Kakudo K (2002). Predictive and prognostic markers for invasive breast cancer. Pathol Int, 52, 186-94
34. Mudduva LK (2009) Quick score of hormone receptor status of breast carcinoma: correlation with other clinicopathological prognostic parameters. Indian J Pathol Microbiol, 52, 159-63
35. Murthy NS, Agarwal UK, Chaudhry K, Saxena S (2007) A study on time trends in incidence of breast cancer - Indian scenario. Eur J Cancer Care, 16, 185-6
36. Naeem M, Khan N, Aman Z, et al (2008) Pattern of breast cancer: experience at lady reading hospital, Peshawar J Ayub Med Coll Abbottabad, 20, 22-5.
37. Navani S, Bhaduri AS (2005). High incidence of oestrogen receptor negative progesterone receptor positive phenotype in Indian breast cancer: Fact or fiction? Indian J Pathol Microbiol, 48, 199-201
38. Nguyen Pl, Taghian AG, Katz MS, et al (2008). Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and Her-2 is associated with local and distant recurrence after breast- conserving therapy. J Clin Oncol, 26, 2373-8.
39. Nielsen To, Hsu Fd, Jensen K, et al (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res, 10, 5367-74.
40. Onitilo AA, Engel JM, Greenlee RT, Mukesh BN (2009). Breast Cancer Subtypes Based on ER/PR and Her2 Expression: Comparison of Clinicopathologic Features and Survival. Clin Med Res 7, 4-13.
41. Parkin Dm, Bray F, Ferlay J, Pisani P (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6.
42. Perou Cm, Sorlie T, Eisen Mb, et al (2000). Molecular portraits of human breast tumours. Nat, 406, 747-52.
43. Raina V, Bhutani M, Bedi R, et al (2005). Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer, 42, 40-5
44. Raju GC, Naraynsingh V (1989) Breast cancer in West Indian women in trinidad. Trop Geogr Med, 41, 257-60.
45. Rambau PF, Chalya PL, Manyama MM, Jackson KJ (2011). Pathological features of breast cancer seen in Northwestern Tanzania: a nine years retrospective study. BMC Res Notes, 4, 214
46. Rampaul RS, Pinder SE, Elaston CW, Ellis IO (2001) Prognostic and predictive factors in primary breast cancer and their role in patient management; the Nottingham breast team. Eur J Surg Oncol, 27, 229-38
47. Rao R, Kuerer H, Cristofanilli M, et al (2008) Breast cancer in the asian Indian population of the United States: a call for screening and education. Breast J, 14, 402-3.
48. Rastogi T, Devesa S, Mangtani P, et al (2008). Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int J Epidemiol, 37, 147-60.
49. Rosen M, Lundin A, Nystrom L, et al (2000). (Incidence and mortality of breast cancer during a 25-year period. International and regional comparisons). Lakartidningen, 97, 294-9.
50. Setiawan VW, Monroe KR, Wilkens LR, et al (2009). HendersonBreast cancer risk factors defined by estrogen and progesterone receptorstatus. Am J Epidemiol, 169, 1251-9.
51. Shet, TWO AUTHOR, et al (2009). Hormone receptors over last 8 years in a cancer referral center in India: What was and what is?. Indian J Pathol and Microbiology, 52, 171-4
52. Sorlie T, Perou Cm, Tibshirani R, et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74.
53. Sorlie T, Tibshirani R, Parker J, et al (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA, 100, 8418-23.
54. Sotiriou C, Neo Sy, Mcshane Lm, et al (2003). Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA, 100, 10393-8.
55. Suvarchala SB, Nageswararao R(2011). Carcinoma Breast histopathological and hormone receptors correlation. J Biosci Tech, 2, 340-8
56. World Cancer Report International Agency For Research On Cancer. June 2003. Retrieved 2009-03-26.
57. Wu TY, West B, Chen YW, Hergert C (2006). Health beliefs and practices related to breast cancer screening in Filipino, Chinese and Asian-Indian women. Cancer Detect Prev, 30, 58-66.